Snf1 protein kinase regulates responses to glucose limitation and other stresses. Snf1 activation requires phosphorylation of its T-loop threonine by partially redundant upstream kinases (Sak1, Tos3, and Elm1). Under favorable conditions, Snf1 is turned off by Reg1-Glc7 protein phosphatase. The reg1 mutation causes increased Snf1 activation and slow growth. To identify new components of the Snf1 pathway, we searched for mutations that, like snf1, suppress reg1 for the slow-growth phenotype. In addition to mutations in genes encoding known pathway components (SNF1, SNF4, and SAK1), we recovered "fast" mutations, designated fst1 and fst2. Unusual morphology of the mutants in the ⌺1278b strains employed here helped us identify fst1 and fst2 as mutations in the RasGAP genes IRA1 and IRA2. Cells lacking Ira1, Ira2, or Bcy1, the negative regulatory subunit of cyclic AMP (cAMP)-dependent protein kinase A (PKA), exhibited reduced Snf1 pathway activation. Conversely, Snf1 activation was elevated in cells lacking the Gpr1 sugar receptor, which contributes to PKA signaling. We show that the Snf1-activating kinase Sak1 is phosphorylated in vivo on a conserved serine (Ser1074) within an ideal PKA motif. However, this phosphorylation alone appears to play only a modest role in regulation, and Sak1 is not the only relevant target of the PKA pathway. Collectively, our results suggest that PKA, which integrates multiple regulatory inputs, could contribute to Snf1 regulation under various conditions via a complex mechanism. Our results also support the view that, like its mammalian counterpart, AMP-activated protein kinase (AMPK), yeast Snf1 participates in metabolic checkpoint control that coordinates growth with nutrient availability.T he Snf1/AMP-activated protein kinase (AMPK) family is highly conserved in eukaryotes, and its members control responses to metabolic stress (reviewed in references 22, 23, and 26). Mammalian AMPK is activated by increased intracellular AMPto-ATP ratios under energy-depleting conditions, such as hypoglycemia and hypoxia. AMPK is also regulated by hormones that control whole-body metabolism, including leptin, adiponectin, and ghrelin. Activated AMPK functions to restore energy equilibrium by stimulating ATP-generating pathways and by inhibiting energy-consuming processes. Important functions of AMPK include stimulation of glucose uptake and fatty acid oxidation, as well as downregulation of protein synthesis and cell growth. Accordingly, defects in AMPK signaling have been linked to diseases from diabetes and obesity to cancer, making AMPK a promising target for activation with drugs (reviewed in references 15 and 21).In the yeast Saccharomyces cerevisiae, Snf1 protein kinase is the ortholog of mammalian AMPK. The most established role of Snf1 is to regulate responses to glucose limitation (for a review, see reference 26). As glucose levels decrease, Snf1 is activated and promotes the use of less preferred (alternative) carbon sources. Activation of Snf1 results from phosphorylation of its conserve...